POSTER: AML-477: The Efficacy of Pivekimab Sunirine in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm With Baseline Skin Involvement in the CADENZA Study

Naveen Pemmaraju, Giovanni Marconi, Pau Montesinos, Andrew A Lane, Luca Mazzarella, David A Sallman, Matthew Ulrickson, Gary Schiller, Harry Erba, Eunice S Wang, Roland B Walter, Eric Deconinck, Ahmed Aribi, Ollivier Legrand, Delphine Lebon, Giovanni Martinelli, Daniel J DeAngelo, Yining Du, Jalaja Potluri, Naval Daver

Open source

DOI: 10.1016/s2152-2650(26)00490-8
Published: 2026-08
Container: Clinical Lymphoma Myeloma and Leukemia
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2152-2650-26-00490-8,
  title = {POSTER: AML-477: The Efficacy of Pivekimab Sunirine in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm With Baseline Skin Involvement in the CADENZA Study},
  author = {Naveen Pemmaraju and Giovanni Marconi and Pau Montesinos and Andrew A Lane and Luca Mazzarella and David A Sallman and Matthew Ulrickson and Gary Schiller and Harry Erba and Eunice S Wang and Roland B Walter and Eric Deconinck and Ahmed Aribi and Ollivier Legrand and Delphine Lebon and Giovanni Martinelli and Daniel J DeAngelo and Yining Du and Jalaja Potluri and Naval Daver},
  year = {2026},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  doi = {10.1016/s2152-2650(26)00490-8},
  url = {https://doi.org/10.1016/s2152-2650(26)00490-8}
}

RIS

TY  - JOUR
TI  - POSTER: AML-477: The Efficacy of Pivekimab Sunirine in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm With Baseline Skin Involvement in the CADENZA Study
AU  - Naveen Pemmaraju
AU  - Giovanni Marconi
AU  - Pau Montesinos
AU  - Andrew A Lane
AU  - Luca Mazzarella
AU  - David A Sallman
AU  - Matthew Ulrickson
AU  - Gary Schiller
AU  - Harry Erba
AU  - Eunice S Wang
AU  - Roland B Walter
AU  - Eric Deconinck
AU  - Ahmed Aribi
AU  - Ollivier Legrand
AU  - Delphine Lebon
AU  - Giovanni Martinelli
AU  - Daniel J DeAngelo
AU  - Yining Du
AU  - Jalaja Potluri
AU  - Naval Daver
PY  - 2026
JO  - Clinical Lymphoma Myeloma and Leukemia
DO  - 10.1016/s2152-2650(26)00490-8
UR  - https://doi.org/10.1016/s2152-2650(26)00490-8
ER  -

APA

Pemmaraju, N., Marconi, G., Montesinos, P., Lane, A. A., Mazzarella, L., Sallman, D. A., Ulrickson, M., Schiller, G., Erba, H., Wang, E. S., Walter, R. B., Deconinck, E., Aribi, A., Legrand, O., Lebon, D., Martinelli, G., DeAngelo, D. J., Du, Y., Potluri, J., & Daver, N. (2026). POSTER: AML-477: The Efficacy of Pivekimab Sunirine in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm With Baseline Skin Involvement in the CADENZA Study. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/s2152-2650(26)00490-8

Source records

crossref · retrieved 2026-09-25T19:38:29.836Z